Tag Archives: EGRNF

Top 10 Medical Stocks To Invest In 2018

32 Great Insurance Jokes

Feds Officially Delay Obama-Era Group Disability Regs, a Little

Trump’s Short-Term Health Move May Get States Hopping

Depression is one of the insurance agent’s worst enemies.

This painful mental health disorder can affect the underwriting process for life insurance, disability insurance, and many other medically underwritten products.

Researchers at the Behavioral Risk Factor Surveillance System (BRFSS), an arm of the Centers for Disease Control and Prevention (CDC), recently posted a new batch of survey data that shows where depression hits the hardest.

(Related: Simple Medicine)

You can use the BRFSS portal system to see how depression is affecting different types of people in every state in the country. The federal government publishes the data free from copyright restrictions. That means you can extract data yourself and put the numbers in blog posts, social media posts, infographics or even ads.

Top 10 Medical Stocks To Invest In 2018: China Evergrande Group (EGRNF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    For example, Evergrande Life – a unit of property developer China Evergrande Group (OTC:EGRNF) – saw its premiums increase more than 40-fold in 2016. It used the proceeds to accumulate a significant stake in rival developer China Vanke (OTC:CVKEY) last year.

Top 10 Medical Stocks To Invest In 2018: Care.com, Inc.(CRCM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Care.com Inc (NYSE: CRCM) got a boost, shooting up 16 percent to $11.01 after the company reported upbeat quarterly results.

    MaxPoint Interactive Inc (NASDAQ: MXPT) shares were also up, gaining 19 percent to $5.44. MaxPoint Interactive reported Q4 earnings of $0.59 per share on revenue of $46.3 million.

Top 10 Medical Stocks To Invest In 2018: KeyCorp(KEY)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    But then there was good news from rail transport company CSX (CSX ) , which saw growth in every one of its business lines. Foot Locker (FL) also surprised to the upside, sending shares up a quick 5.3%. Cramer fave and Action Alerts PLUS holding KeyCorp (KEY) also delivered, as did paint maker Sherwin-Williams (SHW) .

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian said he noticed big options volume in the December weekly, 18 strike calls in KeyCorp (NYSE: KEY). He decided to follow the trade and he is going to hold the position for 1 to 2 days.

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

  • [By Ben Levisohn]

    We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).

Top 10 Medical Stocks To Invest In 2018: Mechel OAO(MTL)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares fell by 1.10 percent. Meanwhile, top losers in the sector included Mechel PAO (ADR) (NYSE: MTL), down 8 percent, and Eagle Materials, Inc. (NYSE: EXP), down 6 percent.

  • [By Lisa Levin]

    Basic materials shares climbed by 2.37 percent in trading on Wednesday. Meanwhile, top gainers in the sector included Handy & Harman Ltd (NYSE: HNH), and Mechel PAO (ADR) (NYSE: MTL).

  • [By Javier Hasse]

    Steel stocks are spiking on Monday afternoon, with AK Steel Holding Corporation (NYSE: AKS) up almost 7.5 percent, United States Steel Corporation (NYSE: X) up about 6.4 percent, Cliffs Natural Resources Inc (NYSE: CLF) up more than 1 percent and Mechel PAO (ADR) (NYSE: MTL) up 16.8 percent. The stocks are not being helped by a few analyst upgrades (although, surely not hurt by them), but seem to be mostly rallying on the back of Donald Trump’s election as president of the United States.

  • [By Shanthi Rexaline]

    Mechel PAO (ADR) (NYSE: MTL) is rallying strongly, rising to a three-year high on roughly 1.7 times its average volume.

    The stock has been on a tear in recent months. After dipping below the $2 level in late April and languishing in the sub-$2 range until August, the stock has nearly tripled in the run up to Monday’s session.

  • [By Lisa Levin]

    Basic materials shares gained around 1.89 percent in trading on Tuesday. Meanwhile, top gainers in the sector included Olympic Steel, Inc. (NASDAQ: ZEUS), and Mechel PAO (ADR) (NYSE: MTL).

Top 10 Medical Stocks To Invest In 2018: Sonoco Products Company(SON)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Deutsche Bank’s Debbie Jones and team contend that Sonoco’s (SON) sale of its plastic-container business to Australia’s Amcor is a sign that M&A is in the offing. They explain why:

    Sonoco announced (9/1) that it is selling its Rigid Plastics Blow Molding operations to Amcor (AMC.AU) for $280M. The transaction price represents a multiple of ~8.0x LTM EBITDA. The business had annual sales of ~$210M and consisted of six production sites in the US and one in Canada. Blow molding operations represented ~10% of Sonocos Consumer Packaging segment sales and EBITDA. The transaction is expected to close in Q4. We expect the proceeds to be used to for M&A focused in flexible packaging, thermoforming and temperature-assured packaging.

    We dont believe Sonoco considered its blow molding operations essential to its growth strategy. This standalone business is also more capital intensive compared to some of its other plastic packaging businesses and SON held a small position in the overall market. Ultimately, the company decided it wants to focus its capital in higher growth platforms. We do not expect the divestment to reduce resin buying scale for Sonoco’s remaining assets given different resin buying. Note that with the divestiture of blow molding and the Canton closures plant (divested in Feb. 2015), this makes the ~$100M reels business the last standalone business in the portfolio, but we do not expect this to be divested in the near-term unless cash is needed for much larger M&A.

    Shares of Sonoco have gained 1.3% to $52.49 at 2:12 p.m. today.

     

Top 10 Medical Stocks To Invest In 2018: Intrepid Potash, Inc(IPI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Monday afternoon, the basic materials shares surged 0.57 percent. Meanwhile, top gainers in the sector included CF Industries Holdings, Inc. (NYSE: CF), up 7 percent, and Intrepid Potash, Inc. (NYSE: IPI), up 7 percent.

  • [By Lisa Levin]

    Friday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Intrepid Potash, Inc. (NYSE: IPI) and L.B. Foster Co (NASDAQ: FSTR).

  • [By Lisa Levin]

    Wednesday afternoon, basic materials shares gained by 1.74 percent. Meanwhile, top gainers in the sector included Intrepid Potash, Inc. (NYSE: IPI), and L.B. Foster Co (NASDAQ: FSTR).

Top 10 Medical Stocks To Invest In 2018: Exxon Mobil Corporation(XOM)

Advisors’ Opinion:

  • [By Dustin Parrett]

    For comparison, Exxon Mobil Corp. (Nasdaq: XOM) is currently valued at $373.91 billion, making it the largest oil company in the United States. Aramco will be worth more than five times Exxon. In fact, Aramco will be worth more than the top “oil majors” of Exxon, Shell, BP, and Chevron combined.

  • [By Paul Ausick]

    Exxon Mobil Corp. (NYSE: XOM) traded up about 1.23% at $85.77. The stock’s 52-week range is $73.55 to $95.55. Volume was about 15% above the daily average of around 11.1 million shares. The company had no specific news Friday.

  • [By Paul Ausick]

    Shares of Exxon Mobil Corp. (NYSE: XOM) dropped nearly 1% last week, to close down 10% for the year to date and keep its position as the worst performing of the 30 stocks included in the Dow Jones Industrial Average index. The DJIA has posted a gain of 4.2% so far this year.

  • [By Paul Ausick]

    The DJIA stock posting the largest daily percentage loss ahead of the close Thursday was Exxon Mobil Corp. (NYSE: XOM) which traded down about 1.94% at $84.61. The stock’s 52-week range is $72.61 to $95.55. Volume was about 15% above the daily average of around 11 million shares. The company had no specific news.

  • [By Paul Ausick]

    Exxon Mobil Corp. (NYSE: XOM) traded down 1.59% at $81.21. The stock’s 52-week range is $80.76 to $95.55. Volume was about equal to the daily average of around 12 million shares. The company had no news, but the large increase in crude inventories really pounded both Exxon and Chevron this afternoon.

  • [By Craig Jones]

    Alan Knuckman of Bulls-Eye Option shared with the viewers of Bloomberg Markets his bullish trading idea in Exxon Mobil Corporation (NYSE: XOM).

    He said Exxon Mobil traded flat over the last year of trade, while Dow Jones gained 25 percent and he expects it's going to catch up.

Top 10 Medical Stocks To Invest In 2018: TransAlta Renewables Inc. (TRSWF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    TransAlta Renewables (OTC:TRSWF) (RNW CA) is a good comp, and trades at 12.3x EBITDA. Similar to NYLD, they own renewables as well as a few gas-fired power plants. The yield on RNW is similar to NYLD at 6.0%. The only real difference is that RNW is less levered (mid-3s on a debt/EBITDA basis), but has clearly overpaid for certain assets in order to help the parent (TransAlta Corp. ticker TA in Canada) to delever.

Top 10 Medical Stocks To Invest In 2018: Madrigal Pharmaceuticals, Inc. (MDGL)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Madrigal (MDGL) has a significant market opportunity to treat NASH. Its MGL-3196 is well positioned as a potential treatment when the illness is at its earliest stages of development, and thereby save the most lives and money.

  • [By Lisa Levin]

    Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) shares shot up 74 percent to $80.43 after the company disclosed that its MGL-3196 achieved primary endpoint in patients with biopsy-proven non-alcoholic steatohepatitis in Phase 2 clinical trial.

Top 10 Medical Stocks To Invest In 2018: Mastercard Incorporated(MA)

Advisors’ Opinion:

  • [By ]

    We’re confident that this year’s list is poised to perform just as our previous picks — which is no small feat. We’ve bagged winners like the 64.3% return from Mastercard (NYSE: MA), 44.3% from Intel (Nasdaq: INTC), 38.9% from Deere (NYSE: DE) and even 101.8% from Skyworks Solutions (Nasdaq: SWKS).

  • [By John Ballard]

    Partnerships play a crucial role in extending PayPal’s reach to new customers and driving higher engagement. The deal with Visa(NYSE:V) opened the door for partnerships with Mastercard(NYSE:MA), Citigroup(NYSE:C), and Fidelity National Information Services (NYSE:FIS). As a result, more deals will come that will increase PayPal’s relevancy and ubiquity in the mobile payment landscape.

  • [By David Zeiler]

    Ethereum has plenty of real-world catalysts driving it already:

    It’s become the foundation of the booming ICO phenomenon, through which cryptocurrency-based startups have raised millions of dollars in a matter of minutes. Most new tokens are either based on Ethereum and/or require users to buy the cryptocurrency with Ethereum. It’s Turing complete, which means the Ethereum network can function as a giant, global computer. That’s what makes Ethereum an ideal platform for applications like smart contracts. And it’s enabled the creation of a new kind of app, “Dapps,” or distributed applications that run on the network. Businesses are adopting it. The 150-plus companies in the Enterprise Ethereum Alliance include some of the world’s biggest and most prestigious corporations, such as JPMorgan Chase & Co. (NYSE:JPM), Microsoft Corp. (Nasdaq: MSFT), Mastercard Inc. (NYSE: MA), and Deloitte.

    Related: What’s the Best Cryptocurrency to Invest in Today?

  • [By Matthew Cochrane]

    With this mindset, it is no wonder that PayPal finished 2016 on a wave of deal-making momentum. In the past 12 months, PayPal completed agreements with a number of financial and tech companies including Alibaba Group Holding Ltd (NYSE: BABA), Citigroup Inc (NYSE: C), Facebook Inc (NASDAQ: FB), Mastercard Inc (NYSE: MA), Visa Inc (NYSE: V), and Vodafone Group Plc (NASDAQ: VOD).

Best Safest Stocks To Own Right Now

After beating the Q4 earnings, Micron’s (MU) stock price surged. Now is the perfect time to ask, is it still a good time to buy?

I believe so. Micron has solid plans to increase its earnings for next year, groundbreaking proprietary technology with unknown potential, a P/E way below the industry average and reasonable debt. It is a healthy company, heavily undervalued and with little risk.

Valuation

Whether compared to its peers or its earnings growth, Micron has a very low P/E ratio. Although sometimes a low P/E ratio is a sign of a company in distress, this is not the case. The long-term debt to revenue ratio seems acceptable, and even low when compared to its peers. From Q3 to Q4, long-term debt was reduced and this trend is expected to continue.

Best Safest Stocks To Own Right Now: Fitbit, Inc.(FIT)

Advisors’ Opinion:

  • [By Bryan Murphy]

    To say Fitbit Inc (NYSE:FIT) went from being a hero to being a zero would be a considerable understatement. In 2015 shortly after its IPO, the world was certain its wearable device was going to revolutionize fitness. Less than two years later, you can barely give the things away.

    It’s enough to convince an investor to mentally write-off the idea of wearables forever. Don’t let the rise and fall (and then more fall) of FIT deter you from the industry though. Fitbit had the right idea, more or less. It just failed to adapt and improve even when it became clear its first wave of products weren’t quite what they were hoped to be for the average fitness-minded consumers (a target market that was part of the problem). There’s a young-and-hungry company called CardioComm Solutions Inc. (OTCMKTS:EKGGF, CVE:EKG) that understands exactly why Fitbit was largely sidelines, and this company has responded before committing to products that miss the mark.

    CardioComm Solutions is the name that makes wellness technology sold under the HeartCheck brand. Those devices are small, handheld ECG (electrocardiogram) readers that put the power of a doctor’s or hospital’s heart-monitoring hardware in the hands of individuals who can use them just as effectively. Its flagship products are the HeartCheck ECG Pen, for consumers – which is available without a prescription – and the HeartCheck ECG monitoring device (available only by prescription) which is a higher-functioning technology.

    More products are on the way too. The ECG ‘Card’ is a credit-card sized device that syncs up with (and is powered by) being in close proximity to a smartphone. Also on the way is the HeartCheck band, worn on the wrist. It does a lot of the same things Fitbit bands do, but with the added benefit of being able to produce clinical-grade ECG readouts viewable not just by the user, but by a doctor, clinic, or call center if that user chooses to deliver them remotely using the comp

  • [By Paul Ausick]

    Fitbit Inc. (NYSE: FIT) dropped about 0.8% on Monday to post a new 52-week low of $7.42 after closing at $7.48 on Friday. The stock’s 52-week high is $30.96. Volume was 20% below the daily average of around 10 million shares. The company had no specific news Monday.

  • [By Peter Graham]

    Small cap fitnessdevice stock and wearables stockFitbit Inc (NYSE: FIT) started off as a high flyer after its 2015 IPO, but those highflying days have largely ended as you can see from its long term performance chart:

  • [By Bryan Murphy]

    As much progress as the remote medical monitoring device market has made in recent years, we’ve still only scratched the surface. The surface has been scratched though. The Dexcom G5 mobile glucose monitor from DexCom, Inc. (NASDAQ:DXCM) is one impressive example. Arguably the first and best entry in the race, DexCom has sent a clear message that consumers and caregivers are ready for a functional device that takes care of itself.

    At the other end of the spectrum is a recent round of products that are less clinical in nature, and more broad-usage friendly. Devices like the Apple Inc. (NASDAQ:AAPL) watch and the Fitbit Inc (NYSE:FIT) line of products are both capable of monitoring heart rates and activity. On the other, neither does it all that well… not like one would expect in a clinical setting. Fitbit has run into a headwind of legal and reputational trouble since it’s been verified that its trackers aren’t all that accurate; Apple avoided such trouble largely because few consumers ever viewed its watches as medical-grade hardware.

    The gap between the Dexcom G5 and the Fitbit fitness trackers, however, is where real opportunity lies. See, the entries to date have proven there is a market for mobile medical devices , but have also proven they have to work as well as the equipment one might expect to find in a doctor’s office or in a hospital.

    It’s this subtle nuance that puts a young company called Biotricity Inc. (OTCMKTS:BTCY) in the spotlight, as it has melded mobile monitoring and quality monitoring, and is now in the midst of making sure they’re marketable… not just to consumers, but to insurance companies (which tend to pay a lot more than the average consumer does). Fitbit missed the mark on both fronts.

    Biotricity is working two different but similar pieces of technology. One is called bioflux, for use by caregivers in a clinical setting, and the other is biolife individuals outside of a clinical setting. Neither is o

Best Safest Stocks To Own Right Now: Hanesbrands Inc.(HBI)

Advisors’ Opinion:

  • [By Rich Duprey]

    If a stock falls hard, particularly one with a durable name in its industry, it could be an opportunity to pick up shares on the cheap. But sometimes, a stock trades at a discount for a very good reason, so let’s take a look at Whirlpool (NYSE:WHR), Hanesbrands (NYSE:HBI), and Vista Outdoor (NYSE:VSTO) to see if they are good values at these lower prices — or just value traps.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 5.9% on Wednesday to post a new 52-week low of $21.50 after closing at $22.86 on Tuesday. The stock’s 52-week high is $31.36. Volume of about 31 million was more than 7 times the daily average of 4.5 million. The company had no specific news.

  • [By Ben Levisohn]

    Today, the Wall Street Journal reported that Kate Spade & Co is considering a sale of the company, following pressure from activist investors given the volatile performance ever since Kate Spade became a mono brand company over 2 years ago. The article cites thatKate Spade has hired an investment bank and has reached out to possible buyers (including other retailers) althoughKate Spade has not responded. This comes at a time when brand houses like VF Corp. (VFC), PVH Corp. (PVH), Hanesbrands (HBI), Michael Kors Holdings (KORS), and Coach have said they are looking to make a branded acquisition, andKate Spade could be one of the strongest candidates. While other brands are seeing negative comps, pulling back on wholesale exposure or restructuring,Kate Spade continues to grow.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 0.6% on Thursday to post a new 52-week low of $21.41 after closing at $21.53 on Wednesday. The stock’s 52-week high is $31.36. Volume was about a third the daily average of around 6 million shares. The company had no specific news Thursday.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 1.2% on Wednesday to post a new 52-week low of $21.44 after closing at $21.70 on Tuesday. The stock’s 52-week high is $31.36. Volume was about half the daily average of around 2.6 million shares. The company had no specific news Wednesday.

Best Safest Stocks To Own Right Now: Globalstar Inc.(GSAT)

Advisors’ Opinion:

  • [By Nicholas Rossolillo]

    Globalstar (NYSEMKT:GSAT) has been growing its total sales, but still struggles with its bottom line. 2016 revenue increased 7%,but another round of financing could be needed to keep things afloat, as operating margin is still deep in the red. The company is making some headway, but time could be running out for the satellite communications provider.

Best Safest Stocks To Own Right Now: China Evergrande Group (EGRNF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    For example, Evergrande Life – a unit of property developer China Evergrande Group (OTC:EGRNF) – saw its premiums increase more than 40-fold in 2016. It used the proceeds to accumulate a significant stake in rival developer China Vanke (OTC:CVKEY) last year.

Best Safest Stocks To Own Right Now: Dillard's, Inc.(DDS)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of The Bon-Ton Stores spiking twice in 2013 and largely falling off since then while large cap Macy’s, Inc (NYSE: M) andsmall capDillard’s, Inc (NYSE: DDS)began falling off in 2015 andsmall cap J C Penney Company Inc (NYSE: JCP) was crushed much earlier:

  • [By Peter Graham]

    A long term performance chart shows shares of The Bon-Ton Stores having two spikes while it along withlarge cap Macy’s, Inc (NYSE: M) and mid capDillard’s, Inc (NYSE: DDS) have posted large declines last year that may or may not have leveled off andsmall cap J C Penney Company Inc (NYSE: JCP) has at least stopped the bleeding:

  • [By Peter Graham]

    A long term performance chart shows shares of The Bon-Ton Stores spiking twice in 2013 and has been falling off for a longer period of time thanlarge cap Macy’s, Inc (NYSE: M) andsmall capDillard’s, Inc (NYSE: DDS)whilesmall cap J C Penney Company Inc (NYSE: JCP) was crushed much earlier: